Your browser doesn't support javascript.
loading
Real-Time Survey of Vaccine Safety of the mRNA-1273 SARS-CoV-2 Vaccine in Workplace Vaccination at Keio University.
Okumura, Kaho; Hara, Azusa; Inada, Isa; Sugiyama, Daisuke; Hoshino, Takahiro; Yakoh, Takahiro; Yokoyama, Hirokazu; Urushihara, Hisashi.
Afiliación
  • Okumura K; Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Hara A; Toshimagaoka Girls Senior High School, 1-25-22 Ikebukuro Toshima-ku, Tokyo 170-0013, Japan.
  • Inada I; Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Sugiyama D; Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Hoshino T; Faculty of Nursing and Medical Care, Keio University, 4411 Endoh, Fujisawa 252-0883, Japan.
  • Yakoh T; Faculty of Economics, Keio University, 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan.
  • Yokoyama H; Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan.
  • Urushihara H; Health Center, Keio University, 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan.
Vaccines (Basel) ; 10(9)2022 Sep 03.
Article en En | MEDLINE | ID: mdl-36146539

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Japón